Page last updated: 2024-08-24

technetium tc 99m mertiatide and Diabetic Angiopathies

technetium tc 99m mertiatide has been researched along with Diabetic Angiopathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuchi, K; Hayashida, K; Horita, Y; Kawano, Y; Kohno, S; Miyazaki, M; Suyama, N; Tadokoro, M; Takishita, S; Taura, K1
Bomanji, JB; Britton, KE; Datseris, IE; Nijran, KS; Nimmon, CC; Siraj, QH; Sonmezoglu, K1

Trials

1 trial(s) available for technetium tc 99m mertiatide and Diabetic Angiopathies

ArticleYear
Acetazolamide assisted Tc-99m MAG3 renography to assess renal blood flow reserve.
    Annals of nuclear medicine, 2003, Volume: 17, Issue:2

    Topics: Acetazolamide; Blood Flow Velocity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Hypertension; Hypertension, Renovascular; Kidney; Male; Middle Aged; Radioisotope Renography; Radiopharmaceuticals; Renal Circulation; Severity of Illness Index; Technetium Tc 99m Mertiatide

2003

Other Studies

1 other study(ies) available for technetium tc 99m mertiatide and Diabetic Angiopathies

ArticleYear
Predictive value of captopril transit renography in essential hypertension and diabetic nephropathy.
    Nuclear medicine communications, 1995, Volume: 16, Issue:1

    Topics: Adult; Aged; Captopril; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Male; Middle Aged; Predictive Value of Tests; Radioisotope Renography; Renal Artery Obstruction; Technetium Tc 99m Mertiatide

1995